Navitas Life Sciences

Maintaining Continuity of Clinical Research in the Era of COVID-19

Thought Leadership Lightning Round
Bio Innovation 2020 | 05 October, 2020


Our President of Clinical Research, Kathy Dimeo, took to the podium to share insights gleaned from our recent patient-centric COVID-19 clinical trials as well as looking at the strategic approaches that we have taken to mitigate and manage non COVID-19 clinical trials throughout the pandemic. The session explores:

  • The impact of COVID-19 on Clinical Research
  • Clinical research responses to the pandemic
  • A Case Study – supporting accelerated execution of a clinical trial for an anti-viral therapeutic treatment for COVID-19
  • With the CRO industry at an inflection point, has COVID-19 changed clinical trials forever?

To download and listen to her session Maintaining Continuity of Clinical Research in the Era of COVID-19 please complete the form.

Please complete form to view presentation
First Name
Last Name
Business Email
Company
Job Title
Country
By submitting this form, I agree to receive email communications from Navitas Life Sciences. Privacy Policy | EU-US & Swiss-US Privacy Shield Policy

© 2020 Navitas Life Sciences | A TAKE Solutions Enterprise  
Privacy Policy EU-US & Swiss-US Privacy Shield Policy